Unlock the USP Case Study: Carcinogenic Potency Categorization Approach (CPCA) for NDSRI Evaluation


This site is protected by reCAPTCHA and Google.

By providing your contact information to USP and pressing the Submit Now button, you consent to receive news and/or promotional alerts via email from USP. You may opt out at any time by following the instructions included in every email alert sent to you by USP. You further agree to the terms of USP’s Privacy Policy

The USP Drug Classification 2026 was published January 29, 2026. The USP Drug Classification (USP DC) is an independent drug classification system intended for use by any stakeholder interested in a classification of drugs for use in formulary development or review in non-acute or outpatient care settings. USP DC is not intended to replace the final review provided by the local pharmacy and therapeutics (P&T) committees.

The classification system can be used for formulary support including but not limited to:
• Building and mapping formularies
• Reviewing formulary adequacy for a minimum baseline of drugs
• Identifying drugs in a particular pharmacologic grouping
• Reviewing formularies and comparing formulary design and benefits

Instructions:

  1. Complete and submit the information on the form below. Please note: (*) indicates required fields.
  2. An e-mail containing the USP DC file will be sent after submission.

We encourage you to provide your feedback on how you use the USP DC and how we can improve it at uspdc@usp.org.

ORADORES

Speaker 1

Ana Claudia Marquim Firmo de Araújo

Gerência de Avaliação de Risco e Eficácia - GEARE, ANVISA, Brazil

Nutricionista de la Universidad de Brasilia, máster en Nutrición Humana...

Speaker 2

Binu Koshy

Senior Scientist, U.S. Pharmacopeia, USA

Binu Koshy, Ph.D., es actualmente líder del equipo y científico principal...

Speaker 3

Ed Shneyvas

Member, NBDS EC, U.S. Pharmacopeia, USA

Ed Shneyvas, Ph.D., tiene más de 25 años de experiencia en la industria nutracéutica...

Speaker 4

Kit Goldman

Senior Director, U.S. Pharmacopeia, USA

Virginia (Kit) S. Goldman, Ph.D., es directora sénior de Suplementos dietéticos...

Speaker 5

Lucy Rodrigues

Especialista em Assuntos Regulatórios, Aché Laboratórios Farmacêuticos, Brazil

Licenciada en Farmacia Bioquímica con énfasis industrial...

Speaker 6

Maria Monagas

Principal Scientist - Science-Dietary Supplements & Herbal Medicines, U.S. Pharmacopeia, USA

La Dra. María Monagas es científica principal del Departamento de Suplementos...

This site is protected by reCAPTCHA and Google.

By providing your contact information to USP and pressing the Submit button, you consent to receive news and/or promotional alerts via email from USP. You may opt out at any time by following the instructions included in every email alert sent to you by USP. You further agree to the terms of USP’s Privacy Policy